EPOTILONE PHARMACEUTICAL DOSED FORMULATION FOR ORAL ADMINISTRATION Russian patent published in 2007 - IPC A61K31/427 A61K47/12 A61K47/02 A61K9/00 A61P35/00 

Abstract RU 2291695 C2

FIELD: medicine, pharmacology, pharmacy.

SUBSTANCE: invention relates to a method for enhancing availability of epotilone analog. Method involves oral administration of epotilone analog or its pharmaceutically acceptable salt, solvate, clathrate, hydrate or a prodrug in mammal in combination with pharmaceutically acceptable buffer neutralizing acid in the amount providing at least 20 mequiv. of capacity for acid neutralization that results to improving bioavailability of epotilone.

EFFECT: improved properties of formulations of drug.

20 cl, 5 tbl, 2 dwg, 9 ex

Similar patents RU2291695C2

Title Year Author Number
PELLET IN ENTEROSOLUBLE SHELL, INCLUDING IXABEPILONE, AND METHOD OF ITS OBTAINMENT 2005
  • Ullakh Izmat
  • Vili Gari Dzhejms
RU2349319C1
FORMULATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE 2010
  • Tatino Ehntoni
  • Kelli Majkl T.
RU2479307C1
USE OF 3-(4-AMINO-1-OXO-1, 3-DIHYDROISOINDOL-2-YL)PIPERIDINE-2,6-DIONE FOR TREATING MANTLE CELL LYMPHOMAS 2007
  • Zeldis Dzherom B.
RU2446804C2
ALKOXY-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL PREPARATIONS COMPRISING THEREOF AND METHOD FOR THEIR USING 2000
  • Uittl Robert R.
  • Sanchilio Frederik D.
  • Stouehll Grehjson Uoker
  • Dzhenkins Duglas Dzhon
  • Uittol Linda
  • Mejer Glenn Alan
  • Fontana Stiven A.
RU2263673C2
PRODRUGS OF ALVOCIDIB HAVING HIGH BIOAVAILABILITY 2016
  • Siddiqui-Jain Adam
  • Bearss David J.
RU2752729C2
METHOD FOR INTRODUCING EPOTILONE ANALOGS FOR TREATING CANCER CASES 2002
  • Bandiopadkhiaj Rebanta
  • Mehlloj Timoti M.
  • Panaggio Andrea
  • Ragkhavan Krishnasvami Srinivas
  • Vehria Sehjlesh Ehmilal
RU2292202C2
COMPOSITIONS AND METHODS FOR TREATING VISUAL ORGAN DISORDERS 2018
  • Kandula, Mahesh
RU2761436C1
ALDOSE REDUCTASE INHIBITORS AND METHODS OF THEIR APPLICATION 2017
  • Wasmuth, Andrew
  • Landry, Donald W.
RU2795195C2
2-PHENYLAMINO-3-CYANOPYRAZOLO[1,5-A]PYRIMIDINE, USEFUL AS INHIBITOR OF LEUKOTRIENE A HYDROLASE 2014
  • Gilford Uilyam
RU2678196C2
DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN 2005
  • Kandi Kennet K.
  • Sastri Srikonda
  • Leung Mansh'Ju
  • Kadri Baladzhi V.
  • Stehch Pol Eh.
RU2440112C2

RU 2 291 695 C2

Authors

Bandiopadkhiaj Rebanta

Mehlloj Timoti M.

Panaggio Andrea

Ragkhavan Krishnasvami Srinivas

Vehria Sehjlesh Ehmilal

Dates

2007-01-20Published

2002-01-25Filed